Vor Biopharma Inc. Insider Trading

VOR

Last 12 months

Insiders sold $27.4M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Peter Kolchinsky sold $14.5M on Apr 6, 16% of their stake, outside a plan. The last open-market buy by an executive or director was in Feb 2021.

Net open-market

−$27.4M

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Feb 2021

Feb 9, 2021

Get an email when VOR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 16	Rajeev M. Shah Large holder	SoldNo plan	213	$19.75	4K	<0.1%	Form 4
Apr 22	Rajeev M. Shah Director	SoldNo plan	165,150	$15.77	$2.6M	6.4%	Form 4
Apr 17 – 20	RA Capital Management, L.p. Large holder	SoldNo plan 2 parts	630,374	$16.14 average	$10.2M	20%	Form 4
Apr 13 – 15	RA Capital Management, L.p. Large holder	SoldNo plan 3 parts	737,989	$16.10 average	$11.9M	19%	Form 4
Apr 8 – 10	Rajeev M. Shah Director	SoldNo plan 4 parts	620,133	$16.50 average	$10.2M	14%	Form 4
Apr 2 – 6	Peter Kolchinsky Director	SoldNo plan 5 parts	849,257	$17.10 average	$14.5M	16%	Form 4
Oct 28, 2025 – Oct 30, 2025	Peter Kolchinsky Director	SoldNo plan 4 parts	400,408	$25.90 average	$10.4M	34%	Form 4
Oct 23, 2025 – Oct 27, 2025	RA Capital Management, L.p. Large holder	SoldNo plan 3 parts	221,166	$28.06 average	$6.2M	16%	Form 4
Oct 20, 2025 – Oct 21, 2025	RA Capital Nexus Fund, L.p. Large holder	SoldNo plan 5 parts	117,050	$29.34 average	$3.43M	7.7%	Form 4
Oct 17, 2025 – Oct 21, 2025	Reprogrammed Interchange LLC Large holder	SoldNo plan 4 parts	37,533	$30.19 average	$1.13M	3.1%	Form 4
Oct 15, 2025 – Oct 17, 2025	Rajeev M. Shah Director	SoldNo plan 16 parts	464,025	$29.54 average	$13.7M	97%	Form 4
Oct 15, 2025 – Oct 16, 2025	Reprogrammed Interchange LLC Large holder	SoldNo plan 4 parts	73,676	$31.88 average	$2.35M	5.8%	Form 4
Oct 10, 2025 – Oct 14, 2025	Reprogrammed Interchange LLC Large holder	SoldNo plan 4 parts	96,657	$31.08 average	$3M	7.0%	Form 4
Oct 8, 2025 – Oct 9, 2025	Reprogrammed Interchange LLC Large holder	SoldNo plan 4 parts	124,146	$33.16 average	$4.12M	8.3%	Form 4
Oct 6, 2025 – Oct 7, 2025	Reprogrammed Interchange LLC Large holder	SoldNo plan 4 parts	98,387	$36.12 average	$3.55M	6.2%	Form 4
Oct 1, 2025 – Oct 3, 2025	Reprogrammed Interchange LLC Large holder	SoldNo plan 8 parts	41,752	$39.43 average	$1.65M	2.5%	Form 4
Sep 16, 2025	Reid Hoffman Large holder	SoldNo plan	447,278	$1.54	689K	1.3%	Form 4
Sep 11, 2025 – Sep 15, 2025	Reid Hoffman Large holder	SoldNo plan 3 parts	984,805	$1.73 average	$1.7M	2.9%	Form 4
Sep 8, 2025 – Sep 10, 2025	Reid Hoffman Large holder	SoldNo plan 3 parts	1,263,647	$1.95 average	$2.46M	3.6%	Form 4
Sep 3, 2025 – Sep 5, 2025	Reid Hoffman Large holder	SoldNo plan 3 parts	1,407,628	$1.97 average	$2.77M	3.8%	Form 4
Aug 27, 2025 – Aug 28, 2025	Reid Hoffman Large holder	SoldNo plan 2 parts	1,417,998	$2.01 average	$2.85M	3.7%	Form 4
Aug 25, 2025 – Aug 26, 2025	Reid Hoffman Large holder	SoldNo plan 2 parts	671,536	$2.10 average	$1.41M	1.7%	Form 4
Feb 13, 2025	Eyal C. Attar Chief Medical Officer	Sold10b5-1 plan	2,227	$1.42	3K	1.7%	Form 4
Feb 10, 2025	Eyal C. Attar Chief Medical Officer	Sold10b5-1 plan	2,554	$1.37	3K	1.9%	Form 4
Dec 30, 2024	Reid Hoffman Large holder	Bought	38,974,101	—	—	New	Form 4
Dec 27, 2024	Eyal C. Attar Chief Medical Officer	Sold10b5-1 plan	10,334	$1.25	13K	11%	Form 4

Jul 16No plan
Rajeev M. Shah
Large holder · sold 213 at $19.75
4K
<0.1% of stake
Apr 22No plan
Rajeev M. Shah
Director · sold 165,150 at $15.77
$2.6M
6.4% of stake
Apr 17 – 20No plan
RA Capital Management, L.p.
Large holder · sold 630,374 at avg $16.14
$10.2M
20% of stake
Apr 13 – 15No plan
RA Capital Management, L.p.
Large holder · sold 737,989 at avg $16.10
$11.9M
19% of stake
Apr 8 – 10No plan
Rajeev M. Shah
Director · sold 620,133 at avg $16.50
$10.2M
14% of stake
Apr 2 – 6No plan
Peter Kolchinsky
Director · sold 849,257 at avg $17.10
$14.5M
16% of stake
Oct 28, 2025 – Oct 30, 2025No plan
Peter Kolchinsky
Director · sold 400,408 at avg $25.90
$10.4M
34% of stake
Oct 23, 2025 – Oct 27, 2025No plan
RA Capital Management, L.p.
Large holder · sold 221,166 at avg $28.06
$6.2M
16% of stake
Oct 20, 2025 – Oct 21, 2025No plan
RA Capital Nexus Fund, L.p.
Large holder · sold 117,050 at avg $29.34
$3.43M
7.7% of stake
Oct 17, 2025 – Oct 21, 2025No plan
Reprogrammed Interchange LLC
Large holder · sold 37,533 at avg $30.19
$1.13M
3.1% of stake
Oct 15, 2025 – Oct 17, 2025No plan
Rajeev M. Shah
Director · sold 464,025 at avg $29.54
$13.7M
97% of stake
Oct 15, 2025 – Oct 16, 2025No plan
Reprogrammed Interchange LLC
Large holder · sold 73,676 at avg $31.88
$2.35M
5.8% of stake
Oct 10, 2025 – Oct 14, 2025No plan
Reprogrammed Interchange LLC
Large holder · sold 96,657 at avg $31.08
$3M
7.0% of stake
Oct 8, 2025 – Oct 9, 2025No plan
Reprogrammed Interchange LLC
Large holder · sold 124,146 at avg $33.16
$4.12M
8.3% of stake
Oct 6, 2025 – Oct 7, 2025No plan
Reprogrammed Interchange LLC
Large holder · sold 98,387 at avg $36.12
$3.55M
6.2% of stake
Oct 1, 2025 – Oct 3, 2025No plan
Reprogrammed Interchange LLC
Large holder · sold 41,752 at avg $39.43
$1.65M
2.5% of stake
Sep 16, 2025No plan
Reid Hoffman
Large holder · sold 447,278 at $1.54
689K
1.3% of stake
Sep 11, 2025 – Sep 15, 2025No plan
Reid Hoffman
Large holder · sold 984,805 at avg $1.73
$1.7M
2.9% of stake
Sep 8, 2025 – Sep 10, 2025No plan
Reid Hoffman
Large holder · sold 1,263,647 at avg $1.95
$2.46M
3.6% of stake
Sep 3, 2025 – Sep 5, 2025No plan
Reid Hoffman
Large holder · sold 1,407,628 at avg $1.97
$2.77M
3.8% of stake
Aug 27, 2025 – Aug 28, 2025No plan
Reid Hoffman
Large holder · sold 1,417,998 at avg $2.01
$2.85M
3.7% of stake
Aug 25, 2025 – Aug 26, 2025No plan
Reid Hoffman
Large holder · sold 671,536 at avg $2.10
$1.41M
1.7% of stake
Feb 13, 202510b5-1 plan
Eyal C. Attar
Chief Medical Officer · sold 2,227 at $1.42
3K
1.7% of stake
Feb 10, 202510b5-1 plan
Eyal C. Attar
Chief Medical Officer · sold 2,554 at $1.37
3K
1.9% of stake
Dec 30, 2024
Reid Hoffman
Large holder · bought 38,974,101
—
New position
Dec 27, 202410b5-1 plan
Eyal C. Attar
Chief Medical Officer · sold 10,334 at $1.25
13K
11% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VOR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with VOR

CompareIntrinsic value

RGENRepligen Corporation

$178.20-0.04%35

EXELExelixis Inc.

$72.75+0.61%97

KYMRKymera Therapeutics Inc.

$136.25+7.21%25

TECHBio-Techne Corporation

$72.73+0.10%52

BIIBBiogen Inc.

$254.46+2.22%39

DBVTDBV Technologies S.A.

$9.94-1.68%10

PALIPalisade Bio Inc.

$1.25+1.63%20

VYGRVoyager Therapeutics Inc.

$1.87+2.19%10

Held by ETFs

VOR is in 26 US ETFs. The largest of them, with VOR's weight in each:

Spot a number that looks wrong? Check it in VOR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VOR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.